Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lyell Immunopharma Inc (NQ: LYEL )

2.780 -0.300 (-9.74%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 818,128
Open 3.090
Bid (Size) 2.760 (9)
Ask (Size) 2.840 (15)
Prev. Close 3.080
Today's Range 2.780 - 3.190
52wk Range 1.770 - 8.740
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
From Lyell Immunopharma, Inc
Via GlobeNewswire
Why Capri Holdings Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) shares jumped 143% to $0.45 after the company announced it received agreement from the FDA on its proposed single confirmatory Phase 3 study of... 
Via Benzinga

Performance

YTD
-17.26%
-17.26%
1 Month
+6.51%
+6.51%
3 Month
+39.70%
+39.70%
6 Month
-20.68%
-20.68%
1 Year
-47.05%
-47.05%

More News

Read More
GSK Walks Away From T-Cell Therapy Pact With Lyell Citing Strategic Actions
Via Benzinga
Analyst Sees A Leader In Solid Tumor Cell Therapy In This Stock
Via Benzinga
Intel, Noah Holdings, Twilio And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2023
From Lyell Immunopharma, Inc
Via GlobeNewswire
Lyell Immunopharma to Participate in BofA Securities Healthcare Conference
From Lyell Immunopharma, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2022
From Lyell Immunopharma, Inc
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Lyell Immunopharma to Participate in 41st Annual J.P. Morgan Healthcare Conference
From Lyell Immunopharma, Inc
Via GlobeNewswire
Lyell Immunopharma Appoints Lynn Seely, MD as President and Chief Executive Officer
From Lyell Immunopharma, Inc
Via GlobeNewswire
Lululemon, Li Auto, Hackett Group And Some Other Big Stocks Moving Lower On Friday
Via Benzinga
Lyell Immunopharma to Participate in BofA Securities Biotech Conference
From Lyell Immunopharma, Inc
Via GlobeNewswire
Lyell Immunopharma to Participate in Barclays Virtual Fireside Chat Series
From Lyell Immunopharma, Inc
Via GlobeNewswire
Lyell Immunopharma Reports Recent Business Highlights and Third Quarter Financial Results
From Lyell Immunopharma, Inc
Via GlobeNewswire
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
Via Benzinga
Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Lyell Immunopharma Presents New Data at SITC Highlighting its Growing Pipeline of T – Cell Reprogramming Technologies and Product Candidates Targeting Solid Tumors
From Lyell Immunopharma, Inc
Via GlobeNewswire
Lyell Immunopharma to Participate in Credit Suisse Healthcare Conference
From Lyell Immunopharma, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
5 Value Stocks In The Healthcare Sector
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.